The French startup plans to offer a precommercial version of its hardware platform to beta testers as early as the end of 2019.
Eurofins will distribute Synthego's sgRNA products to its customers in 44 countries.
The firm said it will use the financing to continue marketing its Engineered Cells and CRISPRevolution product lines and to expand in Europe and Asia.
The firm hasn't yet specified how many shares it is offering or at what price but noted that its stock would trade under the Nasdaq symbol TWST.
Ranomics said it has inked a distribution agreement with Axil Scientific for Ranomics' VariantFind DNA libraries in Singapore.
Arbor will provide reagents to Tataa for its courses on next-generation sequencing applications, while Tataa will distribute Arbor's products in European countries.
Researchers from Synlogic are testing a synthetic biology-based treatment for phenylketonuria, according to the New York Times.
The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.
The New York Times reports that biohackers are also concerned about the potential harms of DIY genetic engineering.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.